FOR IMMEDIATE RELEASE: February 3, 2023 The Therapeutic Goods Administration (TGA) in Australia announced today that they will permit limited use of certain psychedelic-assisted therapies for the treatment …
On April 8, 1986—36 years ago today—the Multidisciplinary Association for Psychedelic Studies (MAPS) was founded by Rick Doblin, Ph.D., as a non-profit organization to fulfill the need to broaden psychedelic …
Summary: “Commercialization simply as profit maximization has raised a lot of tough questions about our ethics in the movement,” says Joy Sun Cooper, Chief of Patient Access and Head of Commercialization …
Summary: On a new episode of Red Table Talk, Jaden Smith, Jada Pinkett Smith, and Gammy Norris speak with author Michael Pollan, journalist Lisa Ling, oncologist Paul Song, and entrepreneur Bob Parsons …
Summary: WIRED investigates the growth of support for psychedelic medicine, highlighting how entrepreneurs from the technology industry are contributing to the field through philanthropic contributions …
Summary: Benzinga considers the potential of psilocybin- and MDMA-assisted therapy as treatment options for individuals with autism spectrum disorders, drawing on previous MAPS-sponsored research of MDMA-assisted …
As long as I can remember, I had a wonderful childhood. Memories of me with my family barbecuing and learning how to bike, swimming for the first time without floaters thanks to my friends help, a van …
“The best way to create access right now is to go through the drug development process and have [psychedelic-assisted therapies] approved by the FDA,” Amy Emerson, CEO of MAPS Public Benefit …
Psychedelic researcher Matthew W. Johnson, Ph.D., Professor of Psychiatry and Behavioral Sciences at Johns Hopkins School of Medicine, recently received a grant from the National Institute on Drug Abuse …
California Senate Bill SB 519, authored by Senator Scott Wiener (D-San Francisco), was put on hold and will now become a two-year bill. The legislation that would decriminalize several psychedelic substances …
Summary: MAPS Founder and Executive Director Rick Doblin, Ph.D., and Roland Griffiths, Ph.D., Founding Director of the Johns Hopkins Center for Psychedelic and Consciousness Research, join WYPR Baltimore’s …
Summary: Pharmacy Times interviews Bia Labate, Ph.D., of MAPS and Chacruna Institute and psychiatric pharmacist Kelan Thomas, Pharm.D., M.S., about the significant scale of current clinical trials involving …
